Inventor
BURKLY LINDA C
US18 patents
⚠️ This page may combine multiple inventors who share the name “BURKLY LINDA C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOGEN INC
6 patentsUS5932214AAug 3, 1999
Treatment for inflammatory bowel disease with VLA-4 blockers
BIOGEN INC90 citations97
US6482409B1Nov 19, 2002
Treatment for inflammatory bowel disease with a vcam-1/1gG fusion protein
BIOGEN INC48 citations96
US5888507AMar 30, 1999
Treatment for insulin dependent diabetes
BIOGEN INC87 citations96
US5871734AFeb 16, 1999
Treatment for asthma with VLA-4 blocking agents
BIOGEN INC58 citations96
US6323027B1Nov 27, 2001
Common gamma chain monoclonal antibody blocking agents
BIOGEN INC39 citations92
US5871732AFeb 16, 1999
Anti-CD4 antibody homologs useful in prophylaxis and treatment of AIDS, ARC and HIV infection
BIOGEN INC68 citations92
BIOGEN IDEC INC
5 patentsUS6770745B2Aug 3, 2004
Common gamma chain blocking agents
BIOGEN IDEC INC24 citations92
US8048422B2Nov 1, 2011
Tweak binding antibodies
BIOGEN IDEC INC7 citations79
US7176184B2Feb 13, 2007
Treatment for inflammatory bowel disease with a fibronectin polypeptide
BIOGEN IDEC INC5 citations73
US8048635B2Nov 1, 2011
Measurement of soluble Tweak levels for evaluation of lupus patients
BIOGEN IDEC INC5 citations67
US9011859B2Apr 21, 2015
Methods for treating TWEAK-related conditions
BIOGEN IDEC INC2 citations59
BURKLY LINDA C
4 patentsUS8293237B2Oct 23, 2012
Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
BURKLY LINDA C40 citations95
US8728475B2May 20, 2014
Methods for treating inflammatory bowel disease
BURKLY LINDA C14 citations82
US8506958B2Aug 13, 2013
Methods for treating TWEAK-related conditions
BURKLY LINDA C6 citations80
US9730947B2Aug 15, 2017
Method of treating lupus nephritis
BURKLY LINDA C0 citations45
UCB PHARMA SA
2 patentsUS8784823B2Jul 22, 2014
Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
UCB PHARMA SA38 citations96
US9321840B2Apr 26, 2016
Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
UCB PHARMA SA2 citations61